Velsera

Attention laboratory professionals! We want to hear from you about the impact of the FDA's Final Rule on Laboratory Developed Tests (LDTs) on your lab and the test menu you offer to your clinical customers. We've created a brief survey to gather your insights and those of your peers. Our goal is to share these valuable insights with our community. https://lnkd.in/exm57Jin Your input is essential in understanding and navigating these regulatory changes. Thank you for contributing to our collective knowledge!  #LaboratoryDevelopedTests #FDA #ClinicalLabs  

Struggling with limited insights from traditional transcriptomics? Expand your research horizons with Velsera! Join our upcoming webinar on single cell and spatial transcriptomics capabilities in biomedical research. Dr. Tatjana Kovacevic shares how single-cell RNA sequencing and spatial transcriptomics are transforming our understanding of tissue cell diversity, developmental processes, and tumor heterogeneity. Register now to secure your spot! 🔸 Date: August 1st, 2024 🔸 Time: 8 AM PST/11 AM EST/5 PM CEST Register Now: https://lnkd.in/gBmXFSKR #Webinar #Research #SingleCell #BiomedicalResearch #DrugDiscovery 

Enhance Your Documentation for FDA Compliance! Discover how current LDT regulations align with the FDA's Stage 1 and 2 requirements and their impact on various lab settings. The FDA's new LDT rule introduces compliance needs like device-focused reporting and labeling, necessitating process adjustments to ensure quality. Whether you're in a hospital lab, commercial lab, specialty lab, small lab, or academic lab, Velsera is here to help guide you! Stay informed and prepared by following our blog series on navigating the FDA LDT ruling. Don’t miss out on essential insights and tips! https://lnkd.in/giDenK94 #FDACompliance #LDT #PrecisionMedicine #EraofVelsera #LabRegulations #MolecularDiagnostics

Join Velsera at #CGC2024 in St. Louis! We’re thrilled to announce that Velsera is a Gold Sponsor at CGC 2024, taking place from August 4-7. Our team is excited to connect with you and discuss the latest advancements in precision medicine. Here’s what you can look forward to: 🔹 Stop by our booth #1 to learn how our Clinical Genomics Workspace can streamline your processes, provide more consistent reporting, and help you prepare for the upcoming FDA ruling on LDTs. 🔹 Check out our two posters. 🔹 Don’t miss our Science Café talk for a quick dive into our latest innovations. We look forward to seeing you there and exploring how we can drive the future of precision medicine together! #PrecisionMedicine #Genomics #LDTs #cancerresearch #EraofVelsera

Ready to streamline your research process? Unlock the power of data-driven research with the Seven Bridges Platform by Velsera! Whether you're analyzing complex genomic data or accelerating drug discovery, the Seven Bridges platform offers tools and insights to drive your projects forward. Explore how our platform can transform your research efficiency and outcomes. Learn more here: https://lnkd.in/gHHjfPpj #Genomics #DrugDiscovery #ResearchTools #Bioinformatics 

From partnering with experts to sharing actionable insights and providing continuous education, discover how we're committed to your success. Velsera’s new Chief Customer Officer, Julie Furt, shares insights into the evolving role of customer success in our industry. Julie discusses the role of the Chief Customer Officer and outlines five key focus areas that will enhance your precision medicine journey with Velsera. Whether it’s ensuring researchers have access to the right data & tools, helping clients navigate the regulatory & reimbursement landscape, or assisting in the interpretation of test results, we are here to support you. Read the full article to learn more about our dedication to transforming the customer experience in precision medicine.  https://lnkd.in/e2uH7d5z    #EraOfVelsera #CustomerSuccess 

Excited for #CGCAnnual2024 in St. Louis? We are too, visit us at booth #1! Our team will be at the Cancer Genomics Consortium from August 4-7 and would love to chat about how we can shape the future of precision medicine together. Streamline your processes and ensure clinical laboratory professionals have instant access to the most accurate data. Velsera’s Clinical Genomics Workspace is your all-in-one solution for clinical NGS data analysis and reporting: 🔸Comprehensive molecular results reporting 🔸 Prioritizes variants based on clinical significance 🔸 Expanded clinical and biological evidence review capabilities 🔸 KB content for TMB, MSI, and co-occurring variants 🔸 Memory of previous reporting decisions 🔸 Generates clinically actionable reports 🔸 Automates draft interpretive text for streamlined reporting Interested in learning more? Schedule a meeting with us or visit us at booth #1! https://lnkd.in/gdEWizYs #ClinicalGenomics #NGS #EraOfVelsera #cancerresearch

Next-generation sequencing has produced petabytes of data, but accessing and analyzing these data remains challenging. Transform your approach to cancer research with the Seven Bridges Cancer Genomics Cloud (CGC), powered by Velsera! Access and analyze vast amounts of cancer data to uncover new insights and drive scientific breakthroughs. Read more about the power of the CGC here: https://lnkd.in/dn4y7ChB #CancerResearch #Genomics #Bioinformatics 

The Cancer Genomics Cloud (CGC) powered by Velsera accelerates cancer research by providing a secure and scalable cloud-based platform to access, share, and analyze multi-omics datasets. Join the CGC’s July webinar featuring Dr. Jo Lynne Rokita from the Children's Hospital of Philadelphia. This webinar will explore the innovative work behind the Open Pediatric Brain Tumor Atlas (OpenPBTA) and its expansion into the Open Pediatric Cancer (OpenPedCan) project. Dr. Rokita will showcase over 50 ready-to-use, reproducible analysis modules and more than 100 somatic outputs, designed to accelerate discovery, validation, and clinical translation in pediatric cancer research. 🔹Save the date: July 24, 2024, 2:00 PM EDT. Register here: https://lnkd.in/gQJdjz9d #CancerGenomicsCloud #Bioinformatics #CancerResearch

Velsera's own Bojan Stankic, Director of Engineering, has been invited to participate in a panel organized by Heapspace and Nordeus! Bojan has been with Velsera for the past 9 years, bringing extensive experience in developing cloud-based platforms and leading engineering teams, particularly in large-scale genomic data analysis. If you're interested in learning more about engineering management, register for the event: https://lnkd.in/d73UrJd7